NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,906 | +3.5% | 3,200 | 0.0% | 0.00% | – |
Q2 2023 | $1,841 | -18.1% | 3,200 | 0.0% | 0.00% | – |
Q1 2023 | $2,249 | -68.9% | 3,200 | 0.0% | 0.00% | – |
Q4 2022 | $7,232 | -51.8% | 3,200 | -32.9% | 0.00% | -100.0% |
Q3 2022 | $15,000 | -25.0% | 4,767 | -9.1% | 0.00% | 0.0% |
Q2 2022 | $20,000 | -23.1% | 5,243 | +7.8% | 0.00% | 0.0% |
Q1 2022 | $26,000 | -52.7% | 4,864 | +19.5% | 0.00% | -50.0% |
Q4 2021 | $55,000 | -8.3% | 4,070 | +21.3% | 0.00% | 0.0% |
Q3 2021 | $60,000 | +5.3% | 3,355 | +1.2% | 0.00% | 0.0% |
Q2 2021 | $57,000 | -14.9% | 3,314 | -1.4% | 0.00% | -33.3% |
Q1 2021 | $67,000 | +19.6% | 3,362 | +1.4% | 0.00% | 0.0% |
Q4 2020 | $56,000 | +5.7% | 3,314 | +3.6% | 0.00% | 0.0% |
Q3 2020 | $53,000 | -29.3% | 3,200 | -1.8% | 0.00% | -40.0% |
Q2 2020 | $75,000 | +29.3% | 3,259 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $58,000 | -17.1% | 3,259 | +0.9% | 0.01% | 0.0% |
Q4 2019 | $70,000 | +12.9% | 3,229 | -4.8% | 0.01% | 0.0% |
Q3 2019 | $62,000 | -46.1% | 3,393 | +5.3% | 0.01% | -50.0% |
Q2 2019 | $115,000 | +13.9% | 3,221 | +7.2% | 0.01% | +11.1% |
Q1 2019 | $101,000 | +2.0% | 3,006 | -0.7% | 0.01% | 0.0% |
Q4 2018 | $99,000 | -73.2% | 3,026 | -50.1% | 0.01% | -76.3% |
Q3 2018 | $370,000 | +12233.3% | 6,062 | +11125.9% | 0.04% | – |
Q2 2018 | $3,000 | – | 54 | +1700.0% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 3 | -99.7% | 0.00% | -100.0% |
Q2 2014 | $13,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |